henry med semaglutide LifeMD vs. Meds: Weight Loss Program Comparison GLP-1 Weight Loss Treatment |

In analysis of TTO based on parameter distributions and the valid cases, the median TTOs (Interquartile range) for SSIBs associated with semaglutide, liraglutide, dulaglutide, and exenatide were 15.5 (0.524.25, n = 18), 9.5 (0.561.5, n = 19), 35.5 (6.560.5, n = 11), and 2.5 (1.5169.5, n = 4) days, respectively (albiglutide was not included in the TTO analysis due to insufficient data)

Tirzepatide, another medication PlexusDx offers, targets two receptors (GLP-1 and GIP) and produces slightly higher average weight loss in some studies

This creates a natural decrease in calorie intake without harsh or unrealistic measures

This may include gradually tapering your medication, continued hormone optimization with BioTE, or integrating supportive treatments like nutritional supplements and lifestyle coaching to help you maintain balance and confidence long-term

What unites these experiences is that discontinuation is rarely driven by lack of clinical benefit

These medications have undergone rigorous testing and provide established safety profiles for treating obesity and helping patients lose weight safely